Sara Calabro
Sara Calabro
Stop FollowingSara Calabro
View as an RSS Feed
View Sara Calabro's Articles BY TICKER:
ARTE,
ASPM,
ATSI,
AZN,
BEC,
BIOV,
BLUD,
BSTE,
BSX,
BUF,
BVX,
CNSO.OB,
CPHD,
CRDC,
CRY,
CRYO,
CSCX,
CTEC,
CUTR,
CYTX,
ELRN,
ENDO,
ENDO.ST,
ENZ,
EVVV,
EZEM,
FOXH,
GB,
GPRO,
HSPO.OB,
IART,
IMA,
INO,
IOX,
ISRG,
LIFC,
LUNA,
MELA,
NGEN,
NMTI.PK,
NXTM,
OPK,
OSIS,
PMD,
PME,
RHHBY.PK,
SGN,
SNN,
SONO,
SONT.PK,
SPNC,
SRDX,
SWTZY.PK,
TSON,
TWTI,
VAS,
VMSI,
XTNT
- Inovio’s Delivery Technology Boosts Cancer Vaccine Potency
- ReAble To Acquire Drug-Delivery Company IOMED For $22 Million
- Smith & Nephew To Market "Spine Fix" Bone Cement
- Smith & Nephew: Deal With Teknimed Inks Has Healthy Potential
- Smith & Nephew Buys BlueSky To Penetrate Wound Care Market
- Schwarz Pharma Moves Ahead With Parkinson’s Patch
- Minrad Wins Anticipated Approval for Inhalation Anesthetic
- Low Visibility Led to Enpath Acquisition By Greatbatch
- Cardiac Science, SonoSite Get Product Placement On Prime Time
- NFL Stars Back HealthSport's Athlete Hydration System
- CryoCor Treats Cardiac Arrhythmias With Extreme Cold
- FDA Approves Cepheid’s Test For Infectious Bacteria
- OSI Systems and Viasys Healthcare Selected As Top Stocks
- Signalife Creates Sales Force for Biomedical Signal Monitors
- Former Endocare Execs Indicted for Fraud
- Tepha Bonds with Lifecell, NMT Medical in New Suture Technology
- BioVeris Acquisition by Roche Highlights Importance of Diagnostics
- Inverness Tops Beckman Coulter's Bid For Biosite
- Xtent: Drug-Eluting Stent Shows Positive Results
